{"story":{"story_id":86387,"version":1,"published_at":"2026-10-15T10:35:19+03:00","status":"PUBLISHED","title":"В России зарегистрировали \"Нимоланцим\" для лечения онкозаболеваний","summary":"Регистрация препарата расширяет возможности применения таргетной терапии в российской онкологической практике","category":"dunya","source_url":"https://tass.ru/obschestvo/28216547","content_hash":"4cae218c67b7e8554fad6a3ce84685de671f1af45dcc7f1ff08d0f2ecda41923","created_at":"2026-10-15 07:56:22","updated_at":"2026-10-15 07:56:22","language":"ru","source_domain":"tass.ru","source_snapshot_path":"C:\\AYRA\\prod\\app\\data\\snapshots\\00086387_tass_ru.html.gz","source_snapshot_hash":"2ad6c182bc924e0511bc5b77ac43dc32af48ad49bfd2fef9f635614ad6ec0570","source_snapshot_at":"2026-10-15T07:56:22.685111+00:00","capture_method":"rss","masa_score":0,"masa_tier":"UNRATED","masa_lenses":null,"masa_is_spam":0,"masa_updated_at":null,"admiralty_grade":null,"admiralty_score":0,"confirmation_level":3,"confirmation_sources":0,"lens_count":0,"threat_level":"DUSUK","threat_weight":10,"ach_count":0,"ach_top":null,"scheduled_at":null,"cycle_interval_hours":null,"status_note":null,"updated_by":null,"image_url":"https://cdn-media.tass.ru/fit/400x300_b2b00b17/tass/m2/uploads/i/20261015/9479771.jpg","independence_group":null,"canonical_id":null,"decision":null},"entities":[],"related":[],"timeline":[{"event_date":"2026-10-15T10:35:19+03:00","event_type":"PUBLICATION","description":"В России зарегистрировали \"Нимоланцим\" для лечения онкозаболеваний"}]}